Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water
2017 StandoutScienceNobel
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
Pertactin β-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteins
2006
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
2007 StandoutScience
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
2007 StandoutNobel
Sculpting conducting nanopore size and shape through de novo protein design
2024 StandoutScienceNobel
Host-pathogen interactions: the seduction of molecular cross talk
2002
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Advances in vaccine adjuvants
1999
Bordetella pertussis infection of human respiratory epithelial cells up-regulates intercellular adhesion molecule-1 expression: role of filamentous hemagglutinin and pertussis toxin
2002
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection
2007
A new coronavirus associated with human respiratory disease in China
2020 StandoutNature
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
1998
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
2007 StandoutNature
Mucosal immunity and vaccines
2005 Standout
IMMUNOLOGY OF HELICOBACTER PYLORI AND PROSPECTS FOR VACCINE
2000
Inflammatory Bowel Disease
2009 Standout
Host defences to Citrobacter rodentium
2003
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM
2003
Burden of Clostridium difficile Infection in the United States
2015 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Evolutionary trends in the genus
2001
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults
1999
Transforming growth factor-β induces development of the TH17 lineage
2006 StandoutNature
Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae
2007
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
1997
Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
2000
Use of mixed infections to study cell invasion and intracellular proliferation of Salmonella enterica in eukaryotic cell cultures
2003
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Glucocorticoids and invasive fungal infections
2003
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
2005
Host Response and Vaccine Development to Helicobacter pylori Infection
1999
Pathogenic Escherichia coli
2004 Standout
Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges
2003
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Cell Surface-localized Nucleolin Is a Eukaryotic Receptor for the Adhesin Intimin-γ of Enterohemorrhagic Escherichia coliO157:H7
2002
Detoxification of Cholera Toxin without Removal of Its Immunoadjuvanticity by the Addition of (STa-related) Peptides to the Catalytic Subunit
2002
Strategies for designing and optimizing new generation vaccines
2001
Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement
2018 StandoutNobel
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Mechanisms of bordetella pathogenesis
2001
Entry Route of Salmonella typhimurium Directs the Type of Induced Immune Response
2007
Colonization of Gnotobiotic Mice with Human Gut Microflora at Birth Protects Against Escherichia coli Heat-Labile Enterotoxin-Mediated Abrogation of Oral Tolerance
2003
Crystal structure of a non‐toxic mutant of heat‐labile enterotoxin, which is a potent mucosal adjuvant
1997
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
2004
Molecular pathogenesis of and transmissible murine colonic hyperplasia
2001
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
2006 Standout
Helicobacter pyloriInfection
2002 Standout
NALT- versus PEYER'S-patch-mediated mucosal immunity
2004
Pore-forming toxins: ancient, but never really out of fashion
2015
Prospects for the Development of a Vaccine Against Helicobacter pylori
1996
Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells
2004 StandoutNobel
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
2003
The great escape: structure and function of the autotransporter proteins
1998
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Salmonella: Immune Responses and Vaccines
2001
Recent advances in the discovery and delivery of vaccine adjuvants
2003
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
2002
Enteropathogenic and enterohaemorrhagic Escherichia coli : more subversive elements
1998
Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract
2000
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
The crystal structure of urease from Klebsiella aerogenes
1995 StandoutScience
Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea
2018
Transverse relaxation-optimized NMR spectroscopy with the outer membrane protein OmpX in dihexanoyl phosphatidylcholine micelles
2001 StandoutNobel
Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
2000 StandoutScience
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
1997
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines
2004
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion
1996
Fast structural responses of gap junction membrane domains to AB5 toxins
2013 StandoutNobel
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Exploitation of host cells by enteropathogenic Escherichia coli
2000
Immune-Stimulating Complexes Induce an IL-12-Dependent Cascade of Innate Immune Responses
1999
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
Central Role for B Lymphocytes and CD4 + T Cells in Immunity to Infection by the Attaching and Effacing Pathogen Citrobacter rodentium
2003
INTERACTION OF ANTIGENS AND ANTIBODIES AT MUCOSAL SURFACES
1997
Mucosal Dendritic Cells
2007
Mucosal Delivery of a Respiratory Syncytial Virus CTL Peptide with Enterotoxin-Based Adjuvants Elicits Protective, Immunopathogenic, and Immunoregulatory Antiviral CD8+ T Cell Responses
2001
Role of Bacterial Intimin in Colonic Hyperplasia and Inflammation
1999 Science
Typical and Atypical EnteropathogenicEscherichia coli
2002
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Intracellular Adhesion Molecule 1 Plays a Key Role in Acquired Immunity to Salmonellosis
2003
Development of a Mouse Model of Helicobacter pylori Infection that Mimics Human Disease
1995 Science
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Cell‐surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon‐γ in the absence of interleukin‐12
2003
Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune Responses
2001
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
1998 StandoutScience
Nasal Immunization of Mice with Human Papillomavirus Type 16 Virus-Like Particles Elicits Neutralizing Antibodies in Mucosal Secretions
1998
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Invasion of rabbit ileal tissue by Enterobacter cloacae varies with the concentration of OmpX in the outer membrane
1994
TLR Signaling Mediated by MyD88 Is Required for a Protective Innate Immune Response by Neutrophils to Citrobacter rodentium
2007
Critical Role of T Cell-Dependent Serum Antibody, but Not the Gut-Associated Lymphoid Tissue, for Surviving Acute Mucosal Infection with Citrobacter rodentium, an Attaching and Effacing Pathogen
2004
Co‐ordination of pathogenicity island expression by the BipA GTPase in enteropathogenic Escherichia coli (EPEC)
2003
Clearance ofCitrobacter rodentiumRequires B Cells but Not Secretory Immunoglobulin A (IgA) or IgM Antibodies
2004
Virulence Functions of Autotransporter Proteins
2001
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis
2007 StandoutNobel
Works of Gill Douce being referenced
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
2001
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
1999
New Vaccines Against Bacterial Toxins
1996
Invasion of HEp-2 cells by strains of Salmonella typhimurium of different virulence in relation to gastroenteritis
1991
Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli
1998
Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma
1999
The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile
2011
Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae
2010
Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells
1996
Genetically Detoxified Mutants of Heat-Labile Toxin from Escherichia coli Are Able To Act as Oral Adjuvants
1999
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins
1995
Biological and genetic characterization of TnphoA mutants of Salmonella typhimurium TML in the context of gastroenteritis
1995
Quantitative studies of invasion of rabbit ileal mucosa by Salmonella typhimurium strains which differ in virulence in a model of gastroenteritis
1994
Salmonella entericaSerovar TyphimuriumsurAMutants Are Attenuated and Effective Live Oral Vaccines
2000
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB
1996
Immunogenicity of aSalmonella typhimurium aroA aroDVaccine Expressing a Nontoxic Domain ofClostridium difficileToxin A
1999
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
1998
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant
1996
Detection of Intimins α, β, γ, and δ, Four Intimin Derivatives Expressed by Attaching and Effacing Microbial Pathogens
1998
Evaluation ofSalmonella typhimuriumMutants in a Model of Experimental Gastroenteritis
1999
Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization.
1998
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin
1997
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
1995
Citrobacter rodentiumInfection in Mice Elicits a Mucosal Th1 Cytokine Response and Lesions Similar to Those in Murine Inflammatory Bowel Disease
1999